View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Theme
  2. Macro
  3. Covid-19
April 30, 2020

NIH/FDA working on standardised language for Covid-19 severity and trial templates

By Victoria Smith

The National Institutes of Health (NIH), as well as the US Food and Drug Administration (FDA) and several medical bioresearchers, are developing standardised Covid-19 severity terminology and clinical trial templates to address biomarkers used in present clinical trials.

The workforce, ACTIV, is attempting to reach an agreement and issue recommendations as quickly as possible. Read more here.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena